On October 25, Gronghui reported that Cofco Biotechnology (000930.SZ) released its third-quarter report. In the first three quarters of 2024, the company achieved revenue of 15.124 billion yuan, a year-on-year increase of 2.74%; net income attributable to shareholders of listed companies was 9.605 million yuan, a year-on-year increase of 102.89%; net loss after deducting non-recurring gains and losses was 40.1558 million yuan, a year-on-year increase of 89.24%; and basic earnings per share was 0.0052 yuan per share.
中粮科技(000930.SZ)：前三季度净利润960.50万元，同比增长102.89%
Cofco Biotechnology (000930.SZ): The net income for the first three quarters was 9.605 million yuan, a year-on-year increase of 102.89%.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated